This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Aummune Ltd.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Erez Lavi: Innovator in Aptamer Technology
Introduction
Erez Lavi is a prominent inventor based in Yavne, Israel. He has made significant contributions to the field of aptamer technology, particularly in the selection of functional aptamers that target T-lymphocytes. With a total of 2 patents to his name, Lavi is recognized for his innovative approaches in biotechnology.
Latest Patents
One of Erez Lavi's latest patents is titled "Methods and Compositions for Selection of Functional Aptamers - T-lymphocyte Binding Aptamers." This patent provides aptamers that specifically target T-lymphocytes and outlines methods for their use. His work in this area has the potential to advance therapeutic strategies in immunology.
Career Highlights
Erez Lavi is currently associated with Aummune Ltd., a company focused on developing novel immunotherapies. His expertise in aptamer technology has positioned him as a key player in the biotechnology sector. Lavi's innovative work continues to influence the development of targeted therapies.
Collaborations
Erez Lavi collaborates with notable colleagues, including Neria Reiss and Ohad Glaich. Their combined efforts contribute to the advancement of research and development in the field of aptamer technology.
Conclusion
Erez Lavi's contributions to the field of biotechnology, particularly through his patents and collaborations, highlight his role as an influential inventor. His work in aptamer technology is paving the way for new therapeutic possibilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile